AR012896A1 - HELICOBACTER PYLORI FLGE POLYPEPTIDE, VACCINE COMPOSITION, USE OF SUCH POLYPEPTIDE FOR THE MANUFACTURE OF COMPOSITIONS, INVITRO DIAGNOSTIC METHOD AND DIAGNOSTIC KIT FOR THE DETECTION OF HELICOBACTER PYLORI INFECTION - Google Patents
HELICOBACTER PYLORI FLGE POLYPEPTIDE, VACCINE COMPOSITION, USE OF SUCH POLYPEPTIDE FOR THE MANUFACTURE OF COMPOSITIONS, INVITRO DIAGNOSTIC METHOD AND DIAGNOSTIC KIT FOR THE DETECTION OF HELICOBACTER PYLORI INFECTIONInfo
- Publication number
- AR012896A1 AR012896A1 ARP980102558A ARP980102558A AR012896A1 AR 012896 A1 AR012896 A1 AR 012896A1 AR P980102558 A ARP980102558 A AR P980102558A AR P980102558 A ARP980102558 A AR P980102558A AR 012896 A1 AR012896 A1 AR 012896A1
- Authority
- AR
- Argentina
- Prior art keywords
- helicobacter pylori
- polypeptide
- compositions
- manufacture
- detection
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 229920001184 polypeptide Polymers 0.000 title abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 206010019375 Helicobacter infections Diseases 0.000 title abstract 3
- 238000009007 Diagnostic Kit Methods 0.000 title abstract 2
- 241000590002 Helicobacter pylori Species 0.000 title abstract 2
- 238000001514 detection method Methods 0.000 title abstract 2
- 238000002405 diagnostic procedure Methods 0.000 title abstract 2
- 229940037467 helicobacter pylori Drugs 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 230000028993 immune response Effects 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56922—Campylobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Communicable Diseases (AREA)
- General Physics & Mathematics (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Un polipéptido FlgE de Helicobacter pylori, o su forma modificada que retiene antigenicidad funcionalmente equivalente, para uso en la induccion deuna respuesta inmune protectora a la infeccion de Helicobacter pylori, composicion de vacuna, uso de dicho polipéptido para la fabricacion decomposiciones, método de diagnostico in vitro y kit de diagnostico para la deteccion de la infeccion por Helicobacter pylori.A Helicobacter pylori FlgE polypeptide, or its modified form that retains functionally equivalent antigenicity, for use in inducing a protective immune response to Helicobacter pylori infection, vaccine composition, use of said polypeptide for the manufacture of compositions, diagnostic method in vitro and diagnostic kit for the detection of Helicobacter pylori infection.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9702242A SE9702242D0 (en) | 1997-06-12 | 1997-06-12 | Vaccine compositions V |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR012896A1 true AR012896A1 (en) | 2000-11-22 |
Family
ID=20407351
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980102558A AR012896A1 (en) | 1997-06-12 | 1998-06-01 | HELICOBACTER PYLORI FLGE POLYPEPTIDE, VACCINE COMPOSITION, USE OF SUCH POLYPEPTIDE FOR THE MANUFACTURE OF COMPOSITIONS, INVITRO DIAGNOSTIC METHOD AND DIAGNOSTIC KIT FOR THE DETECTION OF HELICOBACTER PYLORI INFECTION |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1009764A1 (en) |
| JP (1) | JP2002507118A (en) |
| KR (1) | KR20010013699A (en) |
| CN (1) | CN1259960A (en) |
| AR (1) | AR012896A1 (en) |
| AU (1) | AU8048798A (en) |
| BR (1) | BR9810026A (en) |
| CA (1) | CA2293293A1 (en) |
| EE (1) | EE9900566A (en) |
| HU (1) | HUP0003164A3 (en) |
| ID (1) | ID23052A (en) |
| IL (1) | IL133144A0 (en) |
| IS (1) | IS5288A (en) |
| NO (1) | NO996132L (en) |
| NZ (1) | NZ501427A (en) |
| PL (1) | PL337503A1 (en) |
| SE (1) | SE9702242D0 (en) |
| SK (1) | SK173099A3 (en) |
| TR (1) | TR199903060T2 (en) |
| WO (1) | WO1998056816A1 (en) |
| ZA (1) | ZA984696B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104784687A (en) * | 2015-04-27 | 2015-07-22 | 苏州大学附属第一医院 | Application of flagellar hook protein FlgE of reorganized pseudomonas aeruginosa |
| CN113425717B (en) * | 2021-04-22 | 2023-06-16 | 成都欧林生物科技股份有限公司 | Medicament for improving efficacy of oral helicobacter pylori vaccine and application thereof |
| CN116535472B (en) * | 2023-05-31 | 2024-04-30 | 四川大学华西医院 | Helicobacter pylori recombinant protein antigen FlgK and preparation method and application thereof |
| CN118105473B (en) * | 2024-04-30 | 2024-08-16 | 成都欧林生物科技股份有限公司 | Oral immunogenic composition for preventing or treating Hp infection and application thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5459041A (en) * | 1988-02-18 | 1995-10-17 | Enteric Research Laboratories, Inc. | Campylobacter pylori antigens and uses thereof for detection of Campylobacter pylori infection |
| AR003125A1 (en) * | 1995-06-01 | 1998-07-08 | Astra Ab | BACTERIAL ANTIGENS FOR THE DIAGNOSIS OF INFECTIONS WITH HELICOBACTER PYLORI, A DNA MOLECLE THAT CODES IT, A VECTOR, A HOST CELL, A PROCEDURE FOR PRODUCING THE POLIPEPTIDE, USE OF ELEPIPETICO, AND PROAPILY USE |
-
1997
- 1997-06-12 SE SE9702242A patent/SE9702242D0/en unknown
-
1998
- 1998-06-01 ZA ZA984696A patent/ZA984696B/en unknown
- 1998-06-01 AR ARP980102558A patent/AR012896A1/en unknown
- 1998-06-08 JP JP50228399A patent/JP2002507118A/en active Pending
- 1998-06-08 CN CN98806101A patent/CN1259960A/en active Pending
- 1998-06-08 ID IDW991542A patent/ID23052A/en unknown
- 1998-06-08 EP EP98928772A patent/EP1009764A1/en not_active Withdrawn
- 1998-06-08 WO PCT/SE1998/001093 patent/WO1998056816A1/en not_active Application Discontinuation
- 1998-06-08 CA CA002293293A patent/CA2293293A1/en not_active Abandoned
- 1998-06-08 AU AU80487/98A patent/AU8048798A/en not_active Abandoned
- 1998-06-08 IL IL13314498A patent/IL133144A0/en unknown
- 1998-06-08 HU HU0003164A patent/HUP0003164A3/en unknown
- 1998-06-08 SK SK1730-99A patent/SK173099A3/en unknown
- 1998-06-08 BR BR9810026-2A patent/BR9810026A/en not_active IP Right Cessation
- 1998-06-08 TR TR1999/03060T patent/TR199903060T2/en unknown
- 1998-06-08 KR KR1019997011714A patent/KR20010013699A/en not_active Application Discontinuation
- 1998-06-08 PL PL98337503A patent/PL337503A1/en unknown
- 1998-06-08 NZ NZ501427A patent/NZ501427A/en unknown
- 1998-06-08 EE EEP199900566A patent/EE9900566A/en unknown
-
1999
- 1999-12-08 IS IS5288A patent/IS5288A/en unknown
- 1999-12-10 NO NO996132A patent/NO996132L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20010013699A (en) | 2001-02-26 |
| NO996132L (en) | 2000-01-28 |
| BR9810026A (en) | 2000-09-19 |
| NZ501427A (en) | 2000-09-29 |
| TR199903060T2 (en) | 2000-09-21 |
| IS5288A (en) | 1999-12-08 |
| PL337503A1 (en) | 2000-08-28 |
| SK173099A3 (en) | 2000-06-12 |
| EE9900566A (en) | 2000-06-15 |
| IL133144A0 (en) | 2001-03-19 |
| CA2293293A1 (en) | 1998-12-17 |
| AU8048798A (en) | 1998-12-30 |
| HUP0003164A2 (en) | 2000-12-28 |
| HUP0003164A3 (en) | 2001-10-29 |
| ID23052A (en) | 2000-01-20 |
| CN1259960A (en) | 2000-07-12 |
| JP2002507118A (en) | 2002-03-05 |
| WO1998056816A1 (en) | 1998-12-17 |
| EP1009764A1 (en) | 2000-06-21 |
| ZA984696B (en) | 1999-01-04 |
| NO996132D0 (en) | 1999-12-10 |
| SE9702242D0 (en) | 1997-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200403064T2 (en) | Methods and compounds for the diagnosis and prevention of tuberculosis by immunotherapy. | |
| ES2176232T3 (en) | ADEQUATE VACCINE TO BE USED IN THE PREVENTION AND TREATMENT OF INFECTION WITH HELICOBACTER. | |
| CO5210894A1 (en) | ASSISTANT COMPOSITIONS THAT INCLUDE AN ALUMINUM SALT AND AN IMMUNO STIMULANT | |
| MX9304089A (en) | USE OF GM-CSF AS AN ADJUVANT VACCINE. | |
| ES2062355T3 (en) | PHARMACEUTICAL COMPOSITION INCLUDING LORATADINE, IBUPROPHEN AND PSEUDOEFEDRINE. | |
| AR003006A1 (en) | COMPOSITION OF A COMBINED VACCINE INCLUDING A CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE B CONJUGATED WITH A CARRIER PROTEIN ADSORBED ON ALUMINUM PHOSPHATE AND ONE OR OTHER DIFFERENT ANTIGENS FOR A DIFFERENT PRODUCTION | |
| CO5700790A2 (en) | VACCINE COMPOSITIONS THAT INCLUDE AN INTERLEUCINE 18 AND SAPONINA ASSISTANT SYSTEM | |
| ES2184769T3 (en) | METHODS AND COMPOSITIONS FOR MICROENCAPSULATION OF ANTIGENS TO USE AS VACCINES. | |
| NO991524L (en) | vaccinations | |
| GB9626483D0 (en) | Helicobacter proteins and vaccines | |
| MX9400166A (en) | VEGETABLE PROTEIN MICROSPHERES, HYDROLYZED, MODIFIED AND METHODS FOR THEIR PREPARATION AND USE. | |
| DK0528859T3 (en) | Oral vaccine which includes antigen attached to the surface of red blood cells | |
| ES2195169T3 (en) | VACCINES AGAINST CALMIDIES AND IMMUNOGENIC COMPOSITIONS CONTAINING AN EXTERNAL MEMBRANE ANTIGEN AND METHODS FOR PREPARATION. | |
| MX24890A (en) | SYNTHETIC POLYPEPTIDE, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS IT. | |
| AR012896A1 (en) | HELICOBACTER PYLORI FLGE POLYPEPTIDE, VACCINE COMPOSITION, USE OF SUCH POLYPEPTIDE FOR THE MANUFACTURE OF COMPOSITIONS, INVITRO DIAGNOSTIC METHOD AND DIAGNOSTIC KIT FOR THE DETECTION OF HELICOBACTER PYLORI INFECTION | |
| ATE375514T1 (en) | COMPOSITIONS AND METHODS FOR DETECTING TRYPANOSOMA CRUZI INFECTION | |
| SE9604581D0 (en) | An agent against cancer and virus infections | |
| AR010568A1 (en) | POLYPEPTIDE, VACCINE COMPOSITION, USE OF POLYPEPTIDE IN THE MANUFACTURE OF A COMPOSITION, AND METHOD TO PRODUCE AN IMMUNO-PROTECTIVE RESPONSE AGAINST HELICOBACTER PYLORI INFECTION | |
| BR0009077A (en) | Tuberculosis antigens and methods of using them | |
| ES2308850T3 (en) | ANTIBODIES FOR ANTIGENS OF CELLS OF LANGERHANS OF MAMIFEROS AND ITS USES. | |
| ATE112482T1 (en) | POWDER-FORM DENTAL INVESTMENTS WITH IMPROVED FLOW BEHAVIOR. | |
| DE69637435D1 (en) | SAPONIN COMPOSITIONS AND ITS USE | |
| BR0013574A (en) | Old Moraxella Vaccine | |
| ATE353226T1 (en) | ADJUVANT COMPOSITION CONTAINING FHA OR AN FHA FRAGMENT IN FREE FORM | |
| BR0115095A (en) | Vaccine composition, and method for inducing an immune response in a ruminant to provide immune protection that reduces the severity of or infection with a. marginal |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |